111
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

GO@Fe3O4@ZnO@CS nanocomposite as a novel adsorbent for removal of doxorubicin hydrochloride from aqueous solutions

, , &
Pages 82-91 | Received 06 Jun 2020, Accepted 18 Oct 2020, Published online: 08 Jan 2021
 

Abstract

In this study, GO@Fe3O4 functionalized with ZnO and modified via chitosan (CS) was used with a simple procedure to eliminate doxorubicin hydrochloride (DXH) from aqueous solutions. To that end, crystalline, chemical, and magnetic properties of GO@Fe3O4@ZnO@CS nanocomposite were confirmed via scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), vibrating sample magnetometry (VSM), and X-ray diffraction spectrometry (XRD). The adsorption rate of DXH on the GO@Fe3O4@ZnO@CS nanocomposite was examined under various conditions including equilibrium time = 45 min, adsorbent dose = 0.01 g, solution pH = 7.0, temperature = 25 °C, and primary DXH concentration = 10 mg L−1. Adsorption of DXH was investigated from kinetic (i.e. pseudo first-order (PFO), pseudo second-order (PSO), and Elovich (E)) and equilibrium (i.e. Langmuir (L), Freundlich (F), Temkin (T) and Redlich-Peterson (R-P)) viewpoints. Results of the data analyses indicated the superb performance of GO@Fe3O4@ZnO@CS nanocomposite removing DXH from aqueous solutions. The short time of the adsorption process was another advantage of using this nanocomposite. The maximum adsorption capacity for DXH was obtained as 390 mg g−1.

Acknowledgements

The authors are thankful to the Hamedan Branch, Islamic Azad University for providing instruments to conduct and complete this study.

Disclosure statement

The authors declare that they have no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.